Paul R. Sohmer, M.D. / President and CEO

Paul R. Sohmer, M.D. joined BG Medicine in May of 2013 as President, CEO and member of the board of directors. Dr. Sohmer served as President and Chief Executive Officer of Viracor-IBT Laboratories, Inc., a diagnostic and research laboratory specializing in allergy, immunology, and infectious disease testing from January 2011 to September of 2012. Prior to joining Viracor-IBT Laboratories, from February 2009 to January 2011, Dr. Sohmer served as Chief Executive Officer of Orthocon, Inc., a company that develops, manufactures, markets, and sells implantable products designed to stop bone bleeding. From 2007 to 2009, Dr. Sohmer served on the RadPharm, Inc. board of directors, and from 2008 to 2009, he served as chairman of the board of directors of Molecular Biometrics, Inc. Dr. Sohmer served as Interim CEO of Cylex, Inc. from January through March of 2008 and CEO of Pathway Diagnostics from May to September of 2008. From June 2000 to December 2006, Dr. Sohmer served as Chairman, President and Chief Executive Officer of TriPath Imaging, Inc. (NASDAQ:TPTH). From 1997 to 2000, Dr. Sohmer served as President and Chief Executive Officer of Neuromedical Systems, Inc. (NASDAQ:NSIX). From 1992 to 1996, Dr. Sohmer served as President and Chief Executive Officer of Genetrix, Inc., a genetic testing lab. From 1991-1992, Dr. Sohmer served as Vice President of Professional Services for Nichols Institute. From 1985 to 1991, Dr. Sohmer served as President and Chief Executive Officer of Pathology Institute, Inc., where he led the first commercial introduction of polymerase chain reaction (PCR) for diagnosis of HIV and founded the Chiron Reference Laboratory. Dr. Sohmer received his B.A. from Northwestern University and M.D. from the Chicago Medical School. Dr. Sohmer was named the Ernst and Young Carolinas Life Sciences Entrepreneur of the Year in 2005.

Stephen Hall / Executive Vice President, Chief Financial Officer

Mr. Hall joined BG Medicine from Stemline Therapeutics, Inc., a publicly traded clinical stage biopharmaceutical company, where he held the position of Vice President Finance, Treasurer, Principal Financial and Chief Accounting Officer and assisted in financings in excess of $100m. Prior to Stemline, Mr. Hall served as Chief Financial Officer at both life science and medical device companies, including Orthocon, Inc., Helicos BioSciences Corporation, TriPath Imaging, Inc., and Colorado MEDtech, Inc. Mr. Hall, a certified public accountant, began his professional career with Peat, Marwick, Mitchell & Co., in Chicago, IL. In addition to his experience as an operating CFO, he spent nearly 10 years in commercial banking. He received his AB degree from Harvard College and MBA from Stanford University Graduate School of Business.

Aram Adourian, Ph.D. / Senior Vice President and Chief Scientific Officer

Dr. Adourian joined BG Medicine from the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology. While at MIT, he served as Project Manager for Bioinformatics specializing in the development of novel systems and approaches for biomolecular sequencing, analysis and modeling. Dr. Adourian earned his Ph.D. at Harvard University in Statistical Physics, where he was a recipient of the Rudenberg Research Prize, and received his undergraduate degree in Physics from Cornell University.

Raul Diaz / Vice President, Operations and Information Technologies

Mr. Diaz joined BG Medicine from Newcogen Group Inc.  While at Newcogen Group, he served as Director of Information Technologies where he was responsible for all aspects of the organization’s information technology infrastructure.  Prior to Newcogen, Mr. Diaz spent years as a consultant specializing in information technology architecture, compliance, knowledge management and business continuity.  Mr. Diaz received a Bachelor’s degree in Electrical Engineering from the University of Massachusetts Lowell.